We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRAFT GUIDANCE COVERS CLOZAPINE DISSOLUTION TESTING
Manufacturers considering submitting an abbreviated new drug application for clozapine tablets should conduct in vitro dissolution testing on 12 dosage units of the test product against the 12 units of the reference unit, and report the percent of each unit dissolved, according to a recently released FDA draft guidance.